04:26 PM EST, 03/05/2024 (MT Newswires) -- Karim Saad Temsamani, Director, Chief Executive Officer, on March 01, 2024, sold 34,515 shares in Cardlytics ( CDLX ) for $272,323. Following the Form 4 filing with the SEC, Temsamani has control over a total of 327,298 shares of the company, with 327,298 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1666071/000166607124000027/xslF345X03/wk-form4_1709673820.xml

Price: 7.15, Change: +0.05, Percent Change: +0.7